Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG

Approval Number

SIN16127P

Drug Name

VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG

Product Name

VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG

Approval Date

March 22, 2021

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

C09DA03

ATC Item Name

valsartan and diuretics

Manufacturer Information

Pharmaceutical Manufacturer

NOVARTIS (SINGAPORE) PTE LTD

Manufacturers

Novartis Farma S.p.A

Active Ingredients

Ingredient Name

HYDROCHLOROTHIAZIDE

Strength

25 mg

Drug MonographHydrochlorothiazide

Ingredient Name

VALSARTAN

Strength

160 mg

Drug MonographValsartan

Documents

Package Inserts

Valsartan HCT Sandoz Film-Coated Tablets PI.pdf

Approved: April 6, 2023

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG - HSA Approval | MedPath